Date | Title | Description |
20.10.2023 | IRRAS’s application for delisting has been approved and the Board of Directors has resolved not to publish the interim report for the third quarter of 2023 | IRRAS’s application for delisting has been approved and the Board of Directors has resolved not to publish the interim report for the third quarter of 2023
Fri, Oct 20, 2023 17:45 CET Report this content
IRRAS’s (publ) ("IRRAS") a... |
20.10.2023 | IR Holding Bidco Inc. requests compulsory buy-out and IRRAS applies for delisting | IR Holding Bidco Inc. requests compulsory buy-out and IRRAS applies for delisting
Fri, Oct 20, 2023 00:01 CET Report this content
IR Holding Bidco Inc. (”IR Holding”), which holds more than 90 per cent of the shares and votes in IRRAS AB (p... |
18.09.2023 | Notice to an extraordinary general meeting of IRRAS AB | Notice to an extraordinary general meeting of IRRAS AB
Mon, Sep 18, 2023 20:30 CET Report this content
Notice to an extraordinary general meeting of IRRAS AB with a proposal for a set-off issue of shares for the settlement of short-term loa... |
15.09.2023 | IRRAS Secures Extended Short-Term Loan Agreement | IRRAS Secures Extended Short-Term Loan Agreement
Fri, Sep 15, 2023 08:00 CET Report this content
Stockholm, Sweden (September 15, 2023) – IRRAS AB (publ) (“IRRAS” or the “Company”) today announced an extension of its short-term financing ag... |
24.08.2023 | Supplemental statement from the Independent Bid Committee of IRRAS regarding the public offer from IR Holding Bidco | Supplemental statement from the Independent Bid Committee of IRRAS regarding the public offer from IR Holding Bidco
Thu, Aug 24, 2023 07:45 CET Report this content
Stockholm, Sweden (24 August 2023) – This statement is made by the Independe... |
24.08.2023 | IRRAS Publishes Update on Financial Situation | IRRAS Publishes Update on Financial Situation
Thu, Aug 24, 2023 07:40 CET Report this content
Stockholm, Sweden (24 August 2023) – As previously communicated, IRRAS AB (publ) (the “Company” or ”IRRAS”) is in immediate need of funding. Adopt... |
04.08.2023 | IRRAS announces reassessment of financial outlook | IRRAS announces reassessment of financial outlook
Fri, Aug 04, 2023 07:55 CET Report this content
Stockholm, August 3, 2023 – The Board of Directors of IRRAS AB has today resolved on a revision of the company’s financial outlook. The compan... |
04.08.2023 | IRRAS publishes Interim Report for the period April to June 2023 | IRRAS publishes Interim Report for the period April to June 2023
Fri, Aug 04, 2023 08:00 CET Report this content
Sales during the second quarter of 2023 finished slightly above the same period during the previous year. During the quarter, t... |
04.08.2023 | IRRAS Secures Extended Short-Term Loan Agreement | IRRAS Secures Extended Short-Term Loan Agreement
Fri, Aug 04, 2023 07:45 CET Report this content
Stockholm, Sweden (August 3, 2023) – IRRAS AB (“IRRAS” or the “Company”) today announced an extension of its short-term financing agreement wit... |
02.08.2023 | Q2 Report 2023 - invitation to conference call and audiocast | Q2 Report 2023 - invitation to conference call and audiocast
Wed, Aug 02, 2023 08:00 CET Report this content
Stockholm, August 2, 2023 - On Friday, August 4, at 09.00 CET, IRRAS will host a conference call and an online presentation of its ... |
30.06.2023 | Bulletin from the Annual General Meeting in IRRAS AB (publ) on 30 June 2023 | Bulletin from the Annual General Meeting in IRRAS AB (publ) on 30 June 2023
Fri, Jun 30, 2023 15:02 CET Report this content
The Annual General Meeting in IRRAS AB (publ) has been held on 30 June 2023 and in particular the following resoluti... |
29.06.2023 | IRRAS Shifts Commercial Strategy to Focus Resources on United States Market Opportunity and Publishes Financial Update | IRRAS Shifts Commercial Strategy to Focus Resources on United States Market Opportunity and Publishes Financial Update
Thu, Jun 29, 2023 23:30 CET Report this content
Stockholm, Sweden (29 June 2023) – IRRAS AB (publ) (“IRRAS” or the “Compa... |
01.06.2023 | NOTICE TO ATTEND THE ANNUAL GENERAL MEETING OF IRRAS AB (PUBL) | NOTICE TO ATTEND THE ANNUAL GENERAL MEETING OF IRRAS AB (PUBL)
Thu, Jun 01, 2023 09:00 CET Report this content
The shareholders of IRRAS AB (publ), org.nr 556872-7134 (”the Company”), are hereby invited to the Annual General Meeting to be h... |
17.05.2023 | IRRAS AB publishes Interim Report for the period January to March 2023 | IRRAS AB publishes Interim Report for the period January to March 2023
Wed, May 17, 2023 08:00 CET Report this content
” Encouraging start to 2023 for IRRAS as our total revenue of MSEK 11.2 marked the highest quarterly revenue total in the... |
15.05.2023 | Q1 Report 2023 – invitation to conference call and audiocast | Q1 Report 2023 – invitation to conference call and audiocast
Mon, May 15, 2023 08:30 CET Report this content
Stockholm, May 15, 2023 - On Wednesday, May 17, at 16.00 CET, IRRAS will host a conference call and an online presentation of its Q... |
20.04.2023 | IRRAS Secures Short-term Financing Agreement of MSEK 40 | IRRAS Secures Short-term Financing Agreement of MSEK 40
Thu, Apr 20, 2023 21:25 CET Report this content
Stockholm, Sweden (April 20, 2023) – IRRAS, a commercial-stage medical technology company with a comprehensive portfolio of innovative p... |
16.02.2023 | IRRAS AB publishes Year End Report for the period January to December 2022 | IRRAS AB publishes Year End Report for the period January to December 2022
Thu, Feb 16, 2023 08:00 CET Report this content
Commercial partnership underway to wrap up meaningful year of growth
“Q4 2022 marked the conclusion of a transformati... |
13.02.2023 | IRRAflow System Confirmed to More Effectively Remove Collected Blood and Reduce Catheter Infection Rates than Passive Drainage in Head-to-Head Analysis | IRRAflow System Confirmed to More Effectively Remove Collected Blood and Reduce Catheter Infection Rates than Passive Drainage in Head-to-Head Analysis
Mon, Feb 13, 2023 08:30 CET Report this content
Neurosurgeons from the Jacobs School of ... |
09.02.2023 | Q4 Report 2022 – invitation to conference call and audiocast | Q4 Report 2022 – invitation to conference call and audiocast
Thu, Feb 09, 2023 08:30 CET Report this content
Stockholm, February 9, 2023 - On Thursday, February 16, at 16.00 CET, IRRAS will host a conference call and an online presentation ... |
01.02.2023 | IRRAS Announces Changed Publication Date for the Q4 2022 Interim Report | IRRAS Announces Changed Publication Date for the Q4 2022 Interim Report
Wed, Feb 01, 2023 08:30 CET Report this content
Stockholm, Sweden, February 1, 2023 – IRRAS, a commercial-stage medical technology company with a comprehensive portfoli... |
12.12.2022 | IRRAS Receives US FDA 510(k) Clearance for its Next Generation IRRAflow Control Unit | IRRAS Receives US FDA 510(k) Clearance for its Next Generation IRRAflow Control Unit
Mon, Dec 12, 2022 08:30 CET Report this content
IRRAS received US FDA 510(k) clearance for its class II next-generation IRRAflow control unit that enhances... |
06.12.2022 | Nomination Committee for the IRRAS 2023 Annual General Meeting | Nomination Committee for the IRRAS 2023 Annual General Meeting
Tue, Dec 06, 2022 08:30 CET Report this content
The Nomination Committee for IRRAS AB for the Annual General Meeting 2023 has now been appointed, based on the shareholder struct... |
14.11.2022 | IRRAS Announces Commercial Partnership with Medtronic in the United States for its IRRAflow[®] System | IRRAS Announces Commercial Partnership with Medtronic in the United States for its IRRAflow[®] System
Mon, Nov 14, 2022 18:00 CET Report this content
IRRAS has signed a commercial agreement with Medtronic, starting with a pilot phase where ... |
10.11.2022 | IRRAS AB publishes Interim Report for the period January to September 2022 | STOCKHOLM, Nov. 10, 2022 /PRNewswire/ -- Financial Runway Extended during Q3 as Revenue Growth Continues
"Q3 2022 represented IRRAS' 9th consecutive quarter of revenue growth, and the quarterly revenue of MSEK 11.0 represented 13% grow... |
10.11.2022 | IRRAS AB publishes Interim Report for the period January to September 2022 | IRRAS AB publishes Interim Report for the period January to September 2022
Thu, Nov 10, 2022 08:00 CET Report this content
Financial Runway Extended during Q3 as Revenue Growth Continues
“Q3 2022 represented IRRAS’ 9th consecutive quarter o... |
03.11.2022 | Q3 Report 2022 – invitation to conference call and audiocast | Q3 Report 2022 – invitation to conference call and audiocast
Thu, Nov 03, 2022 08:30 CET Report this content
Stockholm, November 3, 2022 - On Thursday, November 10, at 09.00 CET, IRRAS will host a conference call and an online presentation ... |
24.08.2022 | IRRAS raises SEK 215 million in a rights issue | IRRAS raises SEK 215 million in a rights issue
Wed, Aug 24, 2022 22:15 CET Report this content
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA OR AUSTRALIA OR A... |
23.08.2022 | IRRAS Announces First Patient Treatments at Mount Sinai Health System in New York as Part of the DIVE Study | IRRAS Announces First Patient Treatments at Mount Sinai Health System in New York as Part of the DIVE Study
Tue, Aug 23, 2022 08:30 CET Report this content
Dr. Christopher Kellner from Mount Sinai Health System successfully enrolled the fir... |
10.08.2022 | IRRAS Expands Short-term Financing Agreement | IRRAS Expands Short-term Financing Agreement
Wed, Aug 10, 2022 08:30 CET Report this content
Stockholm, Sweden, August 10, 2022 – IRRAS, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for... |
05.08.2022 | IRRAS publishes prospectus relating to the rights issue of approximately SEK 215 million | IRRAS publishes prospectus relating to the rights issue of approximately SEK 215 million
Fri, Aug 05, 2022 10:15 CET Report this content
2022-08-05
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED ... |
03.08.2022 | Bulletin from the Extraordinary General Meeting in IRRAS AB (publ) on 3 August 2022 | Bulletin from the Extraordinary General Meeting in IRRAS AB (publ) on 3 August 2022
Wed, Aug 03, 2022 11:30 CET Report this content
The Extraordinary General Meeting (the “EGM”) in IRRAS AB (publ) (the “Company”) has been held on 3 August 2... |
22.07.2022 | IRRAS AB publishes Interim Report for the period January to June 2022 | IRRAS AB publishes Interim Report for the period January to June 2022
Fri, Jul 22, 2022 08:00 CET Report this content
Continued progress during Q2 2022
” The second quarter of 2022 provided the latest data point to confirm IRRAS’ progress t... |
15.07.2022 | Q2 Report 2022 – invitation to conference call and audiocast | Q2 Report 2022 – invitation to conference call and audiocast
Fri, Jul 15, 2022 08:30 CET Report this content
Stockholm, July 15, 2022 - On Friday, July 22, at 09.00 CET, IRRAS will host a conference call and an online presentation of its Q2... |
04.07.2022 | IRRAS intends to carry out a rights issue of up to SEK 215 million | IRRAS intends to carry out a rights issue of up to SEK 215 million
Mon, Jul 04, 2022 17:40 CET Report this content
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRI... |
04.07.2022 | IRRAS Presents Business Update and New Financial Targets | IRRAS Presents Business Update and New Financial Targets
Mon, Jul 04, 2022 17:35 CET Report this content
Stockholm, Sweden (July 4, 2022) – IRRAS, a commercial-stage medical technology company with a comprehensive portfolio of innovative pr... |
04.07.2022 | NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF IRRAS AB (PUBL) | NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF IRRAS AB (PUBL)
Mon, Jul 04, 2022 19:00 CET Report this content
The shareholders of IRRAS AB (publ), org.nr 556872-7134 (the “Company”), are hereby invited to the Extraordinary General M... |
24.05.2022 | Bulletin from the Annual General Meeting in IRRAS AB (publ) on 24 May 2022 | Bulletin from the Annual General Meeting in IRRAS AB (publ) on 24 May 2022
Tue, May 24, 2022 12:15 CET Report this content
The Annual General Meeting in IRRAS AB (publ) has been held on 24 May 2022 and in particular the following decisions ... |
19.05.2022 | IRRAS Secures Short-term Financing Agreement of MSEK 30 | IRRAS Secures Short-term Financing Agreement of MSEK 30
Thu, May 19, 2022 08:30 CET Report this content
Stockholm, Sweden (May 19, 2022) – IRRAS, a commercial-stage medical technology company with a comprehensive portfolio of innovative pro... |
27.04.2022 | IRRAS AB publishes Interim Report for the period January to March 2022 | IRRAS AB publishes Interim Report for the period January to March 2022
Wed, Apr 27, 2022 08:00 CET Report this content
Commercial Activity Normalizes, Resulting in Seventh Consecutive Quarter of Revenue Growth
” After two challenging years ... |
25.04.2022 | IRRAS Announces Changed Publication Date for the Q1 2022 Interim Report | IRRAS Announces Changed Publication Date for the Q1 2022 Interim Report
Mon, Apr 25, 2022 08:30 CET Report this content
Stockholm, Sweden (April 25, 2022) – IRRAS, a commercial-stage medical technology company with a comprehensive portfolio... |
25.04.2022 | NOTICE TO ATTEND THE ANNUAL GENERAL MEETING OF IRRAS AB (PUBL) | NOTICE TO ATTEND THE ANNUAL GENERAL MEETING OF IRRAS AB (PUBL)
Mon, Apr 25, 2022 08:30 CET Report this content
The shareholders of IRRAS AB (publ), org.nr 556872-7134 (”the Company”), are hereby invited to the Annual General Meeting to be h... |
11.03.2022 | IRRAS Announces Regulatory Approval of IRRAflow[ ]in Australia | IRRAS Announces Regulatory Approval of IRRAflow[ ]in Australia
Fri, Mar 11, 2022 08:30 CET Report this content
Stockholm, March 11, 2022 – IRRAS, a commercial-stage medical technology company with a comprehensive portfolio of innovative pro... |
03.03.2022 | IRRAS Announces First Global Patient Treatment with Next-Generation IRRAflow[®][ ]System | IRRAS Announces First Global Patient Treatment with Next-Generation IRRAflow[®][ ]System
Thu, Mar 03, 2022 08:30 CET Report this content
Dr. Nicolas Brandmeir from West Virginia University Rockefeller Neuroscience Institute successfully use... |
22.02.2022 | IRRAS Launches Next-Generation of the IRRAflow System in the United States | IRRAS Launches Next-Generation of the IRRAflow System in the United States
Tue, Feb 22, 2022 08:30 CET Report this content
The next-generation IRRAflow control unit has been designed to continue to enhance the procedural workflow for health... |
16.02.2022 | IRRAS AB publishes Year End Report for the period January to December 2021 | IRRAS AB publishes Year End Report for the period January to December 2021
Wed, Feb 16, 2022 08:00 CET Report this content
Sixth Consecutive Quarter of Revenue Growth Posted
“The 4th quarter of 2021 served as an encouraging end to an eventf... |
10.02.2022 | Presentation of Largest Dataset to Date Documenting Use of IRRAflow System Confirms Improved Outcomes Compared to Traditional Drainage Solutions | Presentation of Largest Dataset to Date Documenting Use of IRRAflow System Confirms Improved Outcomes Compared to Traditional Drainage Solutions
Thu, Feb 10, 2022 08:30 CET Report this content
Surgeons from West Virginia University Hospital... |
10.02.2022 | Q4 Report 2021 – invitation to conference call and audiocast | Q4 Report 2021 – invitation to conference call and audiocast
Thu, Feb 10, 2022 08:30 CET Report this content
Stockholm, February 10, 2022 - On Wednesday, February 16, at 09.00 CET, IRRAS will host a conference call and an online presentatio... |
28.01.2022 | IRRAS Announces First Patients Enrolled in ACTIVE Study, a Comparative Clinical Trial Designed to Confirm IRRAflow’s Efficacy to Traditional Passive Drainage | IRRAS Announces First Patients Enrolled in ACTIVE Study, a Comparative Clinical Trial Designed to Confirm IRRAflow’s Efficacy to Traditional Passive Drainage Fri, Jan 28, 2022 08:30 CET
Dr. Anders Korshøj from Aarhus University Hospital suc... |
12.01.2022 | IRRAS Expands Intellectual Property Portfolio with Issuance of Additional Patent for IRRAflow System | IRRAS Expands Intellectual Property Portfolio with Issuance of Additional Patent for IRRAflow System Wed, Jan 12, 2022 08:30 CET
Third patent issued to expand protection of company’s IRRAflow® system, the world’s first irrigating intracrani... |
23.12.2021 | IRRAS Partners with Lovell Government Services to Expand Distribution Capabilities to United States Military Service Members and Veterans | IRRAS Partners with Lovell Government Services to Expand Distribution Capabilities to United States Military Service Members and Veterans Thu, Dec 23, 2021 08:30 CET
IRRAS’ IRRAflow and Hummingbird product lines for neurocritical care will ... |
03.12.2021 | Nomination Committee for the IRRAS 2022 Annual General Meeting | Nomination Committee for the IRRAS 2022 Annual General Meeting Fri, Dec 03, 2021 08:30 CET
The Nomination Committee for IRRAS AB for the Annual General Meeting 2022 has now been appointed, based on the shareholder structure on 30 September ... |
09.11.2021 | IRRAS AB publishes Interim Report for the period, January to September 2021 | IRRAS AB publishes Interim Report for the period, January to September 2021 Tue, Nov 09, 2021 08:00 CET
Fifth Consecutive Quarter of Revenue Growth
“Q3 marked our company’s 5th consecutive quarter of growth, even with increased impact durin... |
04.11.2021 | Q3 Report 2021 – invitation to conference call and audiocast | Q3 Report 2021 – invitation to conference call and audiocast Thu, Nov 04, 2021 08:30 CET
Stockholm, November 4, 2021 - On Tuesday, November 9, at 09.00 CET, IRRAS will host a conference call and an online presentation of its Q3 2021 interim... |
28.10.2021 | IRRAS Accounces Announces First Patient Enrolled in ARCH Study, a Comparative Clinical Trial Designed to Confirm IRRAflow’s Ability to Improve Clearance of Clot after IVH | IRRAS Accounces Announces First Patient Enrolled in ARCH Study, a Comparative Clinical Trial Designed to Confirm IRRAflow’s Ability to Improve Clearance of Clot after IVH Thu, Oct 28, 2021 08:30 CET
Dr. Behnam Rezai Jahromi (Neurosurgeon) a... |
15.10.2021 | IRRAS Accounces Participation and Data Presentations at Two Upcoming, In-Person Neurosurgery Conferences | IRRAS Accounces Participation and Data Presentations at Two Upcoming, In-Person Neurosurgery Conferences Fri, Oct 15, 2021 08:30 CET
Stockholm, October 15, 2021 - IRRAS, a global medical technology company with a comprehensive portfolio of ... |
12.10.2021 | Aarhus University Hospital, a Globally Leading Medical Institution, Begins Use of IRRAS’ IRRAflow System and Initiates Clinical Study to Validate its Efficacy | Aarhus University Hospital, a Globally Leading Medical Institution, Begins Use of IRRAS’ IRRAflow System and Initiates Clinical Study to Validate its Efficacy Tue, Oct 12, 2021 08:30 CET
Aarhus University Hospital in Denmark commenced its c... |
07.10.2021 | IRRAS Announces CE Mark Approval for its Enhanced IRRAflow Dual-Lumen Catheter | IRRAS Announces CE Mark Approval for its Enhanced IRRAflow Dual-Lumen Catheter Thu, Oct 07, 2021 08:30 CET
The enhanced IRRAflow® catheter offers increased kink resistance, which improves the ability to place the catheter, and an altered du... |
29.09.2021 | IRRAS’ IRRAflow[®] System Demonstrates Ability to Treat Pyogenic Ventriculitis through Targeted Delivery of Antibiotics in Case Series Published in Neurosurgery Open | IRRAS’ IRRAflow[®] System Demonstrates Ability to Treat Pyogenic Ventriculitis through Targeted Delivery of Antibiotics in Case Series Published in Neurosurgery Open Wed, Sep 29, 2021 08:30 CET
Neurosurgeons from Helsinki University Hospita... |
26.08.2021 | IRRAS AB publishes Interim Report for the period, January to June 2021 | IRRAS AB publishes Interim Report for the period, January to June 2021 Thu, Aug 26, 2021 08:00 CET
Commercial Growth Continues
“Q2 2021 marks the fourth consecutive quarter of growth for IRRAS despite the challenges of the COVID-19 pandemic... |
19.08.2021 | Q2 Report 2021 – invitation to conference call and audiocast | Q2 Report 2021 – invitation to conference call and audiocast Thu, Aug 19, 2021 08:00 CET
Stockholm, August 19, 2021 - On Thursday, August 26, at 09.00 CET, IRRAS will host a conference call and an online presentation of its Q2 2021 interim ... |
29.07.2021 | IRRAS receives loan financing under European Guarantee Fund | IRRAS receives loan financing under European Guarantee Fund Thu, Jul 29, 2021 18:00 CET
IRRAS signs €10 million loan financing deal with European Investment Bank, supported by the European Guarantee Fund.
IRRAS now has access to €10 million... |
21.07.2021 | IRRAS receives extension of its MDSAP certification and scope expansion of MDSAP & ISO 13485:2016 certifications | IRRAS receives extension of its MDSAP certification and scope expansion of MDSAP & ISO 13485:2016 certifications Wed, Jul 21, 2021 08:30 CET
After completion of successful verification audit by its notified body DEKRA, IRRAS’ Medical De... |
10.06.2021 | IRRAS has carried out a directed share issue of 13,200,00 shares at a subscription price of SEK 5 per share | IRRAS has carried out a directed share issue of 13,200,00 shares at a subscription price of SEK 5 per share Thu, Jun 10, 2021 23:00 CET
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG... |
10.06.2021 | IRRAS intends to carry out a directed issue of shares | IRRAS intends to carry out a directed issue of shares Thu, Jun 10, 2021 17:31 CET
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOU... |
08.06.2021 | IRRAS Receives Quality System Certification under MDSAP and Updated European Union Medical Device Regulation 2017 / 745 | IRRAS Receives Quality System Certification under MDSAP and Updated European Union Medical Device Regulation 2017 / 745 Tue, Jun 08, 2021 10:00 CET
IRRAS’ Quality Management System has been confirmed to comply with stringent standards requi... |
28.05.2021 | IRRAS AB (PUBL)
IRRAS : Announces publication of a Case report from Buffalo General Medical Center, highlights clinical superiority of IRRAflow treatment versus traditional drainage | STOCKHOLM, May 28, 2021 /PRNewswire/ -- IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced the publication of a clinical case report entitled... |
11.05.2021 | IRRAS : Announces Notified Body Transition from GMED to DEKRA, a Global Leader in Inspection and Certifications | STOCKHOLM, May 11, 2021 /PRNewswire/ -- IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, announced today that the CE Mark certificates for its IRRAflow sys... |
10.01.2019 | IRRAS: Intracranial bleeding management device used on first U.S. patient | The IRRAflow device [Image courtesy of IRRAS]IRRAS AB announced today that a healthcare team in Southern California is the first to use the company’s IRRAflow device on a U.S. patient with intracranial bleeding.
A University of California–I... |
11.05.2016 | Irras Raises $11.25M in Funding | Irras AB, a Stockholm, Sweden-based commercial-stage medical technology company, raised $11.25m in funding.
Backers included Serendipity/Ixora, and The Vandel Group, as well as high net-worth healthcare investors in Sweden.
The company will... |